Seelos Therapeutics, Inc. (OTCPK: SEEL.Q)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Seelos Therapeutics, Inc. (OTCPK: SEEL.Q) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $136.00 and employs 8 people.
trading between 0.00 and 0.01.
Tweenvest scores Seelos Therapeutics, Inc. across four factors: quality 13/100, value 45/100. Its strongest factor is value.
SEEL.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $136.00
- Revenue (TTM)
- $2.01M
- P/E
- 0.00
- EPS
- 47.06
- Dividend yield
- —
- Beta (5Y)
- 4.25
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.36M
- Employees
- 8
- Next earnings
- —
About Seelos Therapeutics, Inc.
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
- ISIN
- US81577F4063
- Founded
- 2016
- Listed since
- Apr 19, 1999
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| THC Biomed Intl Ltd.OTCPK: THCB.F | $164.00 | $0.00 | — |
| Aeolus Pharmaceuticals, Inc.OTCPK: AOLS | $152.00 | $— | — |
| Halo Collective Inc.OTCPK: HCAN.F | $151.00 | $— | — |
| MPX International CorporationOTCPK: MPXO.F | $144.00 | $0.00 | — |
| Isodiol International Inc.OTCPK: ISOL.F | $129.00 | $0.00 | — |
| Allied Corp.OTCPK: ALID | $117.00 | $— | — |
| Biome Grow Inc.OTCPK: BIOI.F | $112.00 | $— | — |
| RVL Pharmaceuticals plcOTCPK: RVLP.Q | $111.00 | $0.00 | — |
Figures last refreshed Oct 4, 2026.